These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 39058846)

  • 1. Omalizumab in the treatment of bullous pemphigoid: A single-center series of 15 cases.
    Altan Ferhatoglu Z; Yucesoy SN; Ak T; Demir Y
    Medicine (Baltimore); 2024 Jul; 103(30):e38684. PubMed ID: 39058846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients.
    Alexandre M; Bohelay G; Gille T; Le Roux-Villet C; Soued I; Morin F; Caux F; Grootenboer-Mignot S; Prost-Squarcioni C
    Front Immunol; 2022; 13():874108. PubMed ID: 35514989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omalizumab therapy for bullous pemphigoid.
    Yu KK; Crew AB; Messingham KA; Fairley JA; Woodley DT
    J Am Acad Dermatol; 2014 Sep; 71(3):468-74. PubMed ID: 24954907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Omalizumab on FcεRI and IgE Expression in Lesional Skin of Bullous Pemphigoid.
    Seyed Jafari SM; Gadaldi K; Feldmeyer L; Yawalkar N; Borradori L; Schlapbach C
    Front Immunol; 2019; 10():1919. PubMed ID: 31474990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [EFFECTIVE TREATMENT FOR BULLOUS PEMPHIGOID WITH OMALIZUMAB].
    Neumark M; Tal Y; Zlotogorski A; Molho-Pessach V
    Harefuah; 2020 Jan; 159(1):29-30. PubMed ID: 31930804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgE blockade in autoimmunity: Omalizumab induced remission of bullous pemphigoid.
    James T; Salman S; Stevenson B; Bundell C; Kelly G; Nolan D; John M
    Clin Immunol; 2019 Jan; 198():54-56. PubMed ID: 30557620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin E and bullous pemphigoid.
    Cozzani E; Gasparini G; Di Zenzo G; Parodi A
    Eur J Dermatol; 2018 Aug; 28(4):440-448. PubMed ID: 30325326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literature.
    Balakirski G; Alkhateeb A; Merk HF; Leverkus M; Megahed M
    J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):1778-1782. PubMed ID: 27357866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omalizumab as an alternative therapeutic tool in the treatment of bullous pemphigoid: A case report.
    Vico-Alonso C; Calleja-Algarra A; Aragón-Miguel R; Sánchez-Velázquez A; Velasco-Tamariz V; Ortiz-Romero PL; Monsálvez-Honrubia V
    Dermatol Ther; 2019 Mar; 32(2):e12829. PubMed ID: 30659716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab as a corticosteroid-sparing agent in the treatment of bullous pemphigoid.
    Vassallo C; Somenzi A; De Amici M; Barruscotti S; Brazzelli V
    Dermatol Ther; 2022 Dec; 35(12):e15946. PubMed ID: 36259470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients.
    Chebani R; Lombart F; Chaby G; Dadban A; Debarbieux S; Viguier MA; Ingen-Housz-Oro S; Pham-Ledard A; Bedane CR; Picard-Dahan C; Berthin C; Dereure O; Konstantinou MP; Castel M; Jouen F; Joly P; Seta V; Duvert-Lehembre S; Le Roux C; Quereux G; Sassolas B; Brenaut E; Sin C; Richard MA; Bérard F; Giusti D; Belmondo T; Gille T; Caux F; Prost-Squarcioni C; Grootenboer-Mignot S; Alexandre M;
    Br J Dermatol; 2024 Jan; 190(2):258-265. PubMed ID: 37792727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological treatment for bullous pemphigoid.
    Oren-Shabtai M; Mimouni D; Nosrati A; Atzmony L; Kaplan B; Barzilai A; Baum S
    Front Immunol; 2023; 14():1157250. PubMed ID: 37180101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid.
    Seyed Jafari SM; Feldmeyer L; Bossart S; Simon D; Schlapbach C; Borradori L
    Front Immunol; 2020; 11():611549. PubMed ID: 33584689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effect of omalizumab as an adjuvant treatment to rituximab in patient with refractory bullous pemphigoid.
    Kwon IJ; Kim T; Yoo DS; Min S; Kim SC; Kim JH
    J Dermatol; 2023 May; 50(5):705-709. PubMed ID: 36514846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research progress of omalizumab in the treatment of bullous pemphigoid.
    Ling X; Shou X; Lou Y; Ling J; Zhang M; Yu T; Gu W
    J Dermatol; 2023 May; 50(5):575-587. PubMed ID: 36971190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab.
    Fairley JA; Baum CL; Brandt DS; Messingham KA
    J Allergy Clin Immunol; 2009 Mar; 123(3):704-5. PubMed ID: 19152970
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful Omalizumab Therapy for Bullous Pemphigoid Despite Transient Reaction.
    Ewy S; Pham H; Quan K; Su B; Tachdjian R
    J Drugs Dermatol; 2019 Sep; 18(9):947-949. PubMed ID: 31524994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).
    Milgrom H; Berger W; Nayak A; Gupta N; Pollard S; McAlary M; Taylor AF; Rohane P
    Pediatrics; 2001 Aug; 108(2):E36. PubMed ID: 11483846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bullous pemphigoid successfully treated with omalizumab.
    Gönül MZ; Keseroglu HO; Ergin C; Özcan I; Erdem Ö
    Indian J Dermatol Venereol Leprol; 2016; 82(5):577-9. PubMed ID: 27297272
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and its effects on soluble CD200.
    Yalcin AD; Genc GE; Celik B; Gumuslu S
    Clin Lab; 2014; 60(3):523-4. PubMed ID: 24697134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.